´ëÇÑÁö¹æ°£¿¬±¸È¸ (¿Â¶óÀÎ)KNSG NAFLD(Korean NAFLD Study Group Nonalcoholic Fatty Liver Disease) Symposium 2021 : 2021-10-16±³À°ÀÏÀÚ : 2021-10-16
±³À°Àå¼Ò : ¿Â¶óÀÎ °³ÃÖ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ)KNSG NAFLD(Korean NAFLD Study Group Nonalcoholic Fatty Liver Disease) Symposium 2021ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁö¹æ°£¿¬±¸È¸
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ Áغñ»ç¹«±¹
¿¬¶ôó : 02-373-1005
À̸ÞÀÏ :
kaslsecretariat@hbni.co.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í ȸ¿ø, ÀüÀÓÀÇ, Àü°øÀÇ 30,000¿ø ºñȸ¿ø, ¿Â¶óÀÎȸ¿ø 40,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 09:00~09:20 Metabolomic Biomarkers in NAFLD ±èÈÖ¿µ(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 09:20~09:50 Genetics-based Precision Medicine in NAFLD Silvia Sookoian(Univ. of Buenos Aires Argentina)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 09:50~10:10 Role of Macrophage in NAFLD ÇÑ¿ëÇö(°¿ø´ë)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 10:10~10:30 Inflammatory Aspects of NASH Hepatocarcinogenesis ÇöÁ¤Àº(´Ü±¹´ë)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 10:40~11:00 Influence of Obesity on the Risk of HCC in NAFLD ¼Õ¿ø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 11:00~11:20 Big Data Studies in NAFLD ÀÌÁ¤ÀÏ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 11:20~11:50 Artificial Intelligence and NAFLD Grace L. H. Wong(The Chinese Univ. of Hong Kong Hong Kong)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 11:50~12:10 Various Application of Image Techniques in NAFLD À̽¼ö(¿Ã»êÀÇ´ë)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 12:50~13:10 Treatment Approaches in Lean NAFLD ½Åµ¿Çö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 13:10~13:30 Efficacy and Functionality of Probiotics in NAFLD ¼®±âÅÂ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 13:30~13:50 Metabolic Pharmacotherapy for NAFLD ±è°æ¼ö(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 13:50~14:10 Bariatric Surgery: Benefits and Pitfalls ¹Ú¿µ¼®(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 14:20~14:40 Type 2 Diabetes and NAFLD À̺´¿Ï(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 14:40~15:00 Pregnancy and Maternal NAFLD ±è¿ø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 15:00~15:30 Thyroid Disease and NAFLD Donghee Kim(Stanford Univ. USA)
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 15:30~15:50 Sarcopenia and NAFLD ±è½Â¾÷(¿¬¼¼ÀÇ´ë)